Emergency Medicine Doctors in Bethlehem, PA Accepting Medicare
304 Emergency Medicine doctors found. Showing 181 - 200
 Dr. Kyle Wilson, MD,MPH Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-2489 |
 Christine Depope, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4000 |
Dr. Brian Matthew Berry, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-2888 Fax: 484-884-2885 |
Travis D Cobb, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 801 Ostrum St, St. Luke's Hospital, Bethlehem, PA 18015 Phone: 610-954-4903 |
Min Seok Chae, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4000 |
Dr. Chad Alexander Keller, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-2489 |
Ryan Lee Mcclintock, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 801 Ostrum St, Emergency Medicine, Bethlehem, PA 18015 Phone: 610-954-4903 |
Aaron Josh Deleonguerrero, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4000 |
William Spinosi, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-2489 |
Fady Ghattas, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4000 |
Benjamin Preiss, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-2888 Fax: 484-884-2885 |
Miko Ulas, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 610-402-8000 |
Dr. Jeffery P Reboul, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Road, Bethlehem, PA 18017 Phone: 484-884-2888 |
Daniel Tannenholtz, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4000 |
Leah Marie Rivard, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St Ste 1, Bethlehem, PA 18015 Phone: 484-526-4903 |
Christopher L Kennedy, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 610-751-2853 |
Maksym Mykhlyk, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4000 |
Humaira Bibi, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-2888 |
Dr. Kevin Yanushefski, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4903 |
Dr. Jonathan Williams Walsh, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-2888 |
News Archive
Kinemed updates translational biomarkers strategy at 2010 Conference in Boston
Marc K. Hellerstein, M.D., Ph.D. Co-Founder and Chief of SAB, Kinemed, Inc. presented an "Updated Strategy for Using Disease Predictive Translational Biomarkers in the Rapidly Advancing Field of Causal Pathway Measurements" at the 2010 Personalized and Translational Medicine Conference. In Boston, on September 20-21, 2010.
Antifungal and antidepressant drugs can effectively inhibit COVID-19 virus
New research published in the British Journal of Pharmacology indicates that two currently available medications-an antifungal drug and an antidepressant-can effectively inhibit the virus that causes COVID-19 in laboratory cells.
Decision Resources predicts TNF-alpha inhibitors to dominate rheumatoid arthritis treatment
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
Symposium to discuss latest scientific and clinical advances in treating non-Hodgkins lymphoma
Fifty world-renowned experts in non-Hodgkins lymphoma will convene in New York in November to present the latest scientific and clinical advances in treating a "lost generation" of sufferers-children, young adults and adolescents.
Kona Medical raises $30 million in Series C financing
Kona Medical, Inc. today announced it has raised $30 million in Series C financing to advance its novel hypertension therapy.
› Verified 4 days ago
Emergency Medicine
Internal Medicine
Family Medicine
Psychiatry & Neurology
Anesthesiology
Obstetrics & Gynecology
Radiology
Surgery
Orthopaedic Surgery
Cardiovascular Disease
Pediatrics